Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by Crazydanon Jun 24, 2021 9:41am
224 Views
Post# 33440734

More obvious that is all BS

More obvious that is all BSAchievement by Howard and team. 1-Hiring new staff! Have you seen him or it's just Howard imagination. 2- Do you really think something is going on with antiviral! Again Howard imagination. 3- I think that Brunner as gone now as he's probably seen through Howard misleading strategy. 4- Huaxipharma top 5 pharma, let me laugh!!! 5- Search for tinyi for a while could not find anything. 6- Wanbang who write up a contract for clinical trial with no timeline for accomplishing clinical phase trial!!!! 7- Auditions resigning!! 8- Peoples leaving organisation. 9- Howard or team never buying on open market. 10-Official documents being sign by not authorise people. There are probably 5 years of anything that can translate into decent revenues. As for Michelle, she as to be Biorun, Wesworth and pointer.
<< Previous
Bullboard Posts
Next >>